Home > News > Breast Cancer Drug Offers Better Responses
May 6th, 2005
Breast Cancer Drug Offers Better Responses
One of the latest, most promising treatments for some women with metastatic breast cancer is a new drug that increases the response rate of tumors and causes fewer side effects, researchers say.
The technology behind the drug, nanoparticle albumin-bound paclitaxel (nab-paclitaxel or AbraxaneTM) marks a breakthrough, say Vicente Valero M.D., and Edgardo Rivera, M.D., both in the Department of Breast Medical Oncology at M. D. Anderson.
American Pharmaceutical Partners
Taking the guesswork out of cancer therapy: New molecular test kit predicts patientís survival and drug response August 1st, 2014
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
New imaging agent provides better picture of the gut July 30th, 2014
Zenosense, Inc. July 29th, 2014
Light pulses control graphene's electrical behavior: Finding could allow ultrafast switching of conduction, and possibly lead to new broadband light sensors August 1st, 2014
President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014
Stanford researchers seek 'Holy Grail' in battery design: Pure lithium anode closer to reality with development of protective layer of interconnected carbon domes August 1st, 2014
Air Forceís 30-year plan seeks 'strategic agility' August 1st, 2014